Search
01/11/2023
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes
Santos, JR, Domingo, P, Portilla, J, Gutiérrez, F, Imaz, A, Vilchez, H, Curran, A, Valcarce-Pardeiro, N, Payeras, A, Bernal, E, Montero-Alonso, M, Yzusqui, M, Clotet, B, Videla, S, Moltó, J, Paredes, R. A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes. Open Forum Infectious Diseases. 2023; 10(11)DOI:10.1093/ofid/ofad542. PMID:38023553. IF:3.800(Q2/3D).
01/11/2023
Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer
Nadal E., Oré-Arce M., Remon J., Bernabé-Caro R., Covela-Rúa M., de Castro-Carpeño J., Massutí-Sureda B., Guillot-Morales M., Majem M., Maestu-Maiques I., Morilla-Ruíz I., Gironés R.. Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer. Clinical & Translational Oncology. 2023; 25(11)DOI:10.1007/s12094-023-03286-3. PMID:37566345. IF:2.800(Q2/5D).
01/11/2023
Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation
Serna, N, López-Laguna, H, Aceituno, P, Rojas-Peña, M, Parladé, E, Voltà-Durán, E, Martínez-Torró, C, Sánchez, JM, Di Somma, A, Carratalá, JV, Livieri, AL, Ferrer-Miralles, N, Vázquez, E, Unzueta, U, Roher, N, Villaverde, A. Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation. Pharmaceutics. 2023; 15(11)DOI:10.3390/pharmaceutics15112632. PMID:38004610. IF:4.900(Q1/2D).
01/11/2023
Predictive capacity of FAT1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy
León X., Llansana A., Pérez-Ugarte L., García J., Valero C., Quer M., Camacho M.. Predictive capacity of FAT1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otorri.2023.03.003. PMID:37931687. IF:(Q/D).
01/11/2023
Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis
Pujol A., Llansana A., Pérez-Ugarte L., Sauter B., Quer M., León X.. Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otorri.2022.10.005. PMID:. IF:(Q/D).
01/11/2023
Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas
León, X, Bague, S, Holgado, A, Quer, M, Terra, X, Camacho, M, Aviltes-Jurado, FX. Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otorri.2023.05.001. PMID:. IF:(Q/D).